Face Mask Bacterial Filtration Efficiency (BFE) Testing: Standards, Methods, and Compliance Requirem

Face mask bacterial filtration efficiency (BFE) testing measures how effectively a mask material captures aerosolized bacteria, and it is the decisive performance criterion for medical face masks under ASTM F2100 and EN 14683. Accredited third-party laboratories conduct BFE tests using a Staphylococcus aureus biological aerosol to verify compliance with regulatory requirements in major global markets. This article explains the applicable standards, sample types, test methodology, calculation principles, acceptance criteria, and frequently asked questions related to face mask BFE testing.

Technical Overview

Bacterial filtration efficiency (BFE) is a quantitative measure of a face mask material's ability to block bacteria-carrying aerosol droplets, expressed as the percentage of a standardized bacterial aerosol captured by the mask relative to an unfiltered control. In a typical sneeze, cough, or speech event, bacteria are carried on saliva and mucus droplets with a mean particle size of approximately 3 micrometers, which is the basis for the biological aerosol used in BFE testing.

Most medical face masks achieve filtration through a middle layer of melt-blown polypropylene nonwoven fabric, which captures particles through a combination of mechanical mechanisms (inertial impaction, interception, and diffusion) and electrostatic attraction from electret charging. BFE testing verifies that this layered structure performs as intended under controlled laboratory conditions.

BFE should be distinguished from particulate filtration efficiency (PFE), which uses inert submicron particles such as latex spheres or sodium chloride aerosols, and from viral filtration efficiency (VFE). The principal test methods and specifications for BFE include ASTM F2101 and ASTM F2100 in the United States, EN 14683 in Europe, and GB 19083, YY 0469, and GB/T 38880 in China.

Testing Samples

Medical and Surgical Face Masks

Surgical and procedure masks are regulated medical devices in most jurisdictions and are the primary category subject to mandatory BFE requirements. They are evaluated against ASTM F2100 performance levels or the EN 14683 mask types, both of which specify minimum BFE thresholds.

Filtering Respirators (N95, KN95, FFP2)

Tight-fitting respirators are certified primarily on inert particulate filtration, for example under EN 149 or 42 CFR Part 84 in the United States. BFE testing is nevertheless frequently performed on respirators as supplementary characterization, for market-specific claims, or as part of a manufacturer's internal quality program.

Daily-Use and Civilian Masks

Community and civilian masks, including children's masks under GB/T 38880, are increasingly subject to voluntary or market-driven BFE requirements, with a common target of at least 95 percent for masks promoted as having protective filtration performance.

Raw Filter Materials

Manufacturers of melt-blown nonwoven fabric and composite laminate materials submit rolls or cut specimens for BFE testing during incoming inspection, electret treatment validation, and batch release, ensuring material conformity before mask assembly.

Testing Items

BFE is the core test item, but accreditation bodies and product standards typically evaluate it alongside a complementary set of performance parameters:

• Bacterial filtration efficiency (BFE) per ASTM F2101 or EN 14683 Annex B
• Particulate filtration efficiency (PFE) at 0.1 micrometers per ASTM F2299 or equivalent methods
• Differential pressure (breathability) across the mask material
• Resistance to penetration by synthetic blood (splash resistance)
• Microbial cleanliness (bioburden) per EN ISO 11737-1
• Material structural and safety requirements such as flammability and headband strength where applicable

Testing Methods

Biological Aerosol Challenge Method (ASTM F2101 / EN 14683)

The internationally recognized BFE test exposes the mask specimen to an aerosol of Staphylococcus aureus (ATCC 6538) generated by a nebulizer and delivered through an aerosol chamber at a constant airflow of 28.3 liters per minute. The aerosol has a mean particle diameter of approximately 3.0 micrometers, simulating bacteria-laden respiratory droplets. The bacterial challenge level is controlled so that the total count recovered from control runs falls within an acceptance window, typically between 1,700 and 3,000 colony-forming units (CFU).

Downstream of the specimen holder, a six-stage cascade impactor or agar plate sampler collects any bacteria that penetrate the mask. The agar plates are then incubated at approximately 35 to 37 degrees Celsius for 24 to 48 hours, after which colonies are counted. A minimum of five specimens is tested together with positive controls without a mask specimen, and negative controls are used to confirm that the aerosol system is free of extraneous contamination.

BFE Calculation

Bacterial filtration efficiency is calculated from the average colony counts of the control (C) and the test specimen (T) as follows: BFE (%) = (C minus T) divided by C, multiplied by 100. The result is reported as a percentage, frequently exceeding 99 percent for high-performance medical mask materials.

Specimen Conditioning

Prior to testing, specimens are conditioned in a controlled environment, typically at 21 plus or minus 5 degrees Celsius and 85 plus or minus 5 percent relative humidity for at least four hours, to normalize the electrostatic and moisture state of the material and ensure reproducible results.

Acceptance Criteria by Standard

• ASTM F2100 Level 1 medical masks: BFE greater than or equal to 95 percent
• ASTM F2100 Level 2 and Level 3 medical masks: BFE greater than or equal to 98 percent
• EN 14683 Type I masks: BFE greater than or equal to 95 percent
• EN 14683 Type II and Type IIR masks: BFE greater than or equal to 98 percent
• YY 0469 surgical masks (China): BFE greater than or equal to 95 percent
• GB 19083 medical protective masks and GB/T 38880 daily masks (China): BFE greater than or equal to 95 percent

Laboratory and Biosafety Requirements

Because the method uses a viable pathogenic microorganism, BFE testing must be performed by trained personnel in accredited third-party laboratories or qualified microbiology facilities operating under appropriate biosafety containment, with validated aerosol generation, flow control, incubation, and colony counting procedures.

Applications

BFE test reports serve multiple regulatory and commercial purposes across the mask supply chain:

• Regulatory registration and market access, including US FDA 510(k) submissions referencing ASTM F2100, EU MDR conformity with EN 14683, and NMPA registration under YY 0469 or GB 19083
• Export compliance verification for masks shipped between jurisdictions with differing standard frameworks
• Manufacturing quality control, batch release, and incoming inspection of melt-blown filter media
• Research and development of electret-treated nonwovens, multilayer composite structures, and new mask designs
• Procurement verification by hospitals, government agencies, and distributors who require independent confirmation of filtration claims

FAQ

What is bacterial filtration efficiency (BFE)?

BFE is the percentage of a standardized aerosol of Staphylococcus aureus, with a mean droplet size of about 3 micrometers, that is captured by a mask material compared with an unfiltered control. A BFE of 98 percent means only 2 percent of the bacterial aerosol penetrates the specimen.

Which microorganism is used for the test and why?

The BFE method uses Staphylococcus aureus ATCC 6538 because it is a non-motile, Gram-positive coccus of approximately 1 micrometer in diameter that attaches well to aerosol droplets, forms countable colonies on tryptic soy agar, and represents a clinically relevant respiratory pathogen size.

How many specimens are required for a BFE test?

Both ASTM F2101 and EN 14683 require a minimum of five specimens cut from completed masks or material samples, tested together with positive and negative controls. Laboratories often request additional pieces to cover sampling, conditioning, and any repeat runs.

What is the difference between BFE and PFE?

BFE uses a viable bacterial aerosol with roughly 3-micrometer droplets, while PFE uses inert particles, typically 0.1-micrometer latex spheres or sodium chloride aerosols, to challenge the material. PFE evaluates fine particulate capture, whereas BFE represents droplet-borne bacterial filtration, and the two values are not directly interchangeable.

Does a high BFE result guarantee protection against viruses?

No. BFE is a material performance indicator measured under controlled laboratory conditions with specific droplet sizes. It does not by itself demonstrate fit, virus filtration, or real-world protection, which is why standards evaluate BFE together with breathability, splash resistance, and, for respirators, particulate filtration and total inward leakage.

How long does BFE testing take?

Typical turnaround is about five to ten working days from sample receipt, depending on conditioning time, incubation and colony counting, control verification, and report issuance. Accredited third-party laboratories can confirm exact schedules based on sample volume and queue conditions.